Skip to main content

Key Product Details

Species Reactivity

Human

Applications

Immunoprecipitation, Western Blot

Label

Unconjugated

Antibody Source

Monoclonal Mouse IgG3 Kappa Clone # 127A

Format

BSA Free

Concentration

1 mg/ml

Product Specifications

Immunogen

GST-MYST3 (172-321aa) recombinant protein human MYST3

Clonality

Monoclonal

Host

Mouse

Isotype

IgG3 Kappa

Theoretical MW

225 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.

Applications for MYST3 Antibody (127A) - BSA Free

Application
Recommended Usage

Immunoprecipitation

1:10 - 1:500

Western Blot

1:100 - 1:2000
Application Notes
Positive control(s): HEK293, K562, U937 cells.

Formulation, Preparation, and Storage

Purification

Protein A purified

Formulation

PBS

Format

BSA Free

Preservative

0.02% Sodium Azide

Concentration

1 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: MYST3

MYST3 is a component of the MOZ/MORF complex which has a histone H3 acetyltransferase activity. Histone acetyltransferase which may act as a transcriptional coactivator for RUNX1 and RUNX2

Long Name

Histone acetyltransferase KAT6A

Alternate Names

KAT6A, MOZ, MYST-3, RUNXBP2, ZNF220

Gene Symbol

KAT6A

Additional MYST3 Products

Product Documents for MYST3 Antibody (127A) - BSA Free

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for MYST3 Antibody (127A) - BSA Free

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...